According to Ironwood Pharmaceuticals 's latest financial reports the company's total liabilities are $0.81 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.81 B | 82.39% |
2022-12-31 | $0.44 B | -13.99% |
2021-12-31 | $0.52 B | 4.92% |
2020-12-31 | $0.49 B | 0.12% |
2019-12-31 | $0.49 B | -6.14% |
2018-12-31 | $0.52 B | -11.31% |
2017-12-31 | $0.59 B | -7.35% |
2016-12-31 | $0.64 B | 22.73% |
2015-12-31 | $0.52 B | 117.63% |
2014-12-31 | $0.24 B | 0.01% |
2013-12-31 | $0.24 B | 180.4% |
2012-12-31 | $85.85 M | -13.38% |
2011-12-31 | $99.12 M | -30.1% |
2010-12-31 | $0.14 B | -69.22% |
2009-12-31 | $0.46 B | 24.95% |
2008-12-31 | $0.36 B | 17.34% |
2007-12-31 | $0.31 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
AstraZeneca AZN | $64.79 B | 7,826.91% | ๐ฌ๐ง UK |
Nektar Therapeutics
NKTR | $0.26 B | -67.33% | ๐บ๐ธ USA |